Zydus Lifesciences Gets Mexican Nod for Cancer Biosimilar
July 22, 2024 11:30
Zydus Lifesciences secures Mexican regulatory approval for Bhava, a biosimilar cancer treatment, expanding its reach to Latin America. The drug is used for various cancers, including colorectal and...